Overactive Bladder
Conditions
Interventions
Experimental group:Ling-Shao Zao-Ren Formula Granule
Control group:Tolterodine Tartrate Sustained Release Tablets
Sponsors
Xiyuan Hospital, CACMS
Eligibility
Sex/Gender
Female
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1. Compliance with Diagnostic Standards of Traditional Chinese and Western Medicine; 2. Women aged 18 and 60 years; 3. Chinese and Western medicines for the treatment of OAB have not been used in the past week; 4. Sign informed consent and volunteer.
Exclusion criteria
Exclusion criteria: (1) Patients with urinary tract infection and lower urinary tract obstruction, pregnancy and lactation; (2) Neurogenic bladder; (3) Patients with urethral dysfunction; (4) Patients with urinary retention and those with residual urine volume > 50 ml, patients with gastric**retention; (5) Patients with myasthenia gravis and patients with toxic megacolon; (6) Patients with ulcerative colitis and narrow angle glaucoma; (7) Patients allergic to tolterodine tartrate tablets and patients with severe liver and kidney dysfunction; (8) The researcher judged that the patients could not cooperate with the completion of the study. (9) fail to use drugs according to regulations, fail to judge the curative effect, or have incomplete data that affect the judgement of curative effect, etc.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| OABSS;Urine NGF; Urine BDNF;Blood routine; electrocardiogram; liver and kidney function;; | — |
Contacts
Public ContactJianwu Shen
Xiyuan Hospital, CACMS
Outcome results
None listed